C.H. Compton

799 total citations
5 papers, 492 citations indexed

About

C.H. Compton is a scholar working on Physiology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, C.H. Compton has authored 5 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Immunology and Allergy. Recurrent topics in C.H. Compton's work include Asthma and respiratory diseases (4 papers), Phosphodiesterase function and regulation (2 papers) and Allergic Rhinitis and Sensitization (2 papers). C.H. Compton is often cited by papers focused on Asthma and respiratory diseases (4 papers), Phosphodiesterase function and regulation (2 papers) and Allergic Rhinitis and Sensitization (2 papers). C.H. Compton collaborates with scholars based in United Kingdom, United States and France. C.H. Compton's co-authors include Neil Barnes, Richard Nieman, B.S. Sihra, Onn Min Kon, A. B. Kay, Thomas B. Leonard, S. Brøgger Christensen, Don E. Griswold, Theodore J. Torphy and Mary S. Barnette and has published in prestigious journals such as The Lancet, European Respiratory Journal and Thorax.

In The Last Decade

C.H. Compton

5 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.H. Compton United Kingdom	5	345	250	174	113	71	5	492
Lorna Wood Canada	10	405 1.2×	171 0.7×	124 0.7×	200 1.8×	189 2.7×	12	541
Lam Bk United States	5	452 1.3×	202 0.8×	44 0.3×	105 0.9×	94 1.3×	8	555
Andrew R. Fischer United States	7	520 1.5×	314 1.3×	43 0.2×	82 0.7×	142 2.0×	7	643
Mary Fitzgerald United Kingdom	7	132 0.4×	211 0.8×	84 0.5×	53 0.5×	13 0.2×	18	344
Grazyna Pinis Poland	4	350 1.0×	219 0.9×	30 0.2×	56 0.5×	105 1.5×	8	422
Susan S. Meltzer United States	7	272 0.8×	153 0.6×	35 0.2×	86 0.8×	81 1.1×	8	330
S. Kundu United States	8	486 1.4×	428 1.7×	42 0.2×	41 0.4×	133 1.9×	20	576
Khuder Alagha France	7	313 0.9×	266 1.1×	46 0.3×	150 1.3×	49 0.7×	13	473
M Cembrzýńska-Nowak Poland	7	205 0.6×	74 0.3×	53 0.3×	171 1.5×	50 0.7×	25	362
D Branscheid Germany	7	106 0.3×	242 1.0×	101 0.6×	32 0.3×	15 0.2×	16	400

Countries citing papers authored by C.H. Compton

Since Specialization

Citations

This map shows the geographic impact of C.H. Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.H. Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.H. Compton more than expected).

Fields of papers citing papers by C.H. Compton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.H. Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.H. Compton. The network helps show where C.H. Compton may publish in the future.

Co-authorship network of co-authors of C.H. Compton

This figure shows the co-authorship network connecting the top 25 collaborators of C.H. Compton. A scholar is included among the top collaborators of C.H. Compton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.H. Compton. C.H. Compton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Compton, C.H., Richard Nieman, Jeffrey D. Edelson, et al.. (2001). Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. The Lancet. 358(9278). 265–270. 152 indexed citations

2.

Kon, Onn Min, B.S. Sihra, Li‐Cher Loh, et al.. (2001). The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. European Respiratory Journal. 18(1). 45–52. 52 indexed citations

3.

Torphy, Theodore J., Mary S. Barnette, David C. Underwood, et al.. (1999). ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic. Pulmonary Pharmacology & Therapeutics. 12(2). 131–135. 134 indexed citations

4.

Kon, Onn Min, B.S. Sihra, C.H. Compton, et al.. (1998). Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. The Lancet. 352(9134). 1109–1113. 118 indexed citations

5.

O'Shaughnessy, T, et al.. (1997). Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. Thorax. 52(6). 519–522. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact